The Use of Off-Label Medications in Newborn Infants Despite an Approved Alternative Being Available—Results of a National Survey

The Use of Off-Label Medications in Newborn Infants Despite an Approved Alternative Being Available—Results of a National Survey

Neonates continue to be treated with off-label or unlicensed drugs while in hospital. However, some medications that have previously been used in adults underwent clinical testing and licensure for use with a different indication in the neonatal and pediatric population. Almost always, the marketing...

Full description

Bibliographic Details
Main Authors: Alex Veldman, Eva Richter, Christian Hacker, Doris Fischer
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Pharmacy
Subjects:
off-label drug use
neonate
NICU
European pediatric regulation
prescribing
Online Access:https://www.mdpi.com/2226-4787/10/1/19

Similar Items

Similar Items